Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
Clinical trial NCT04144192 · COMPLETED
Trial details
- NCT number
- NCT04144192
- Sponsor
- Scilex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-28
- Primary completion
- 2014-07-24
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.